The EPIICAL Consortium applauds the significant progress in the fight against HIV/AIDS in children, presented by Dr. Deborah Persaud at the 2024 Conference on Retroviruses and Opportunistic Infections (CROI). Research…
The CARMA Global study has successfully met its recruitment target and recruited 99 children and adolescents living with HIV from across the globe. The study includes children and adolescents who…
In the quest to enhance our understanding of paediatric HIV and improve treatment outcomes, the EPIICAL project has worked tirelessly for the past eight years to gather and generate knowledge on HIV…
The EPIICAL General Assembly was held online and in person in Venice on 2-4 November 2022. It brought together 80 participants from 29 organisations from the EPIICAL consortium. Attendees came…
In July and August 2022, as part of the preparations for the initiation of enrolments into CARMA Global, investigators and site staff were oriented on study procedures and the correct…
Congratulations to study teams on the acceptance of their abstracts to AIDS 2022
In 2016 the Early-treated Perinatally HIV-infected individuals: Improving Children’s Actual Life (EPIICAL) consortium began gathering scientists and clinicians specialising in paediatric HIV
It takes a community of people working together to achieve the results we are looking for: eradicating HIV in children
The CIPHER Grant Programme directly supports the development of early stage investigators, awarding up to US$150,000 for up to two years to address research gaps in paediatric and adolescent HIV…
The CARMA team in the EPIICAL consortium have just published the article Early ART initiation during infancy preserves natural killer cells in young European adolescents living with HIV (CARMA cohort) in…